A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1Kevin P. Egan, Harvey M. Friedman, Giulia Tebaldi et al.|Viruses|2023Cited by 28
Antibodies to Crucial Epitopes on HSV-2 Glycoprotein D as a Guide to Dosing an mRNA Genital Herpes VaccineLauren M. Hook, Harvey M. Friedman, Gary H. Cohen et al.|Viruses|2022Cited by 17
Novel Adjuvant S-540956 Targets Lymph Nodes and Reduces Genital Recurrences and Vaginal Shedding of HSV-2 DNA When Administered with HSV-2 Glycoprotein D as a Therapeutic Vaccine in Guinea PigsSita Awasthi, Harvey M. Friedman, John M. Lubinski et al.|Viruses|2023Cited by 3
Preventing neonatal herpes: Protection after maternal mRNA-lipid nanoparticle vaccination equals or exceeds that from prior maternal genital infection in murine modelsAngela Desmond, Harvey M. Friedman, John M. Lubinski et al.|The Journal of Immunology|2022Cited by 0